Capital Point Ltd. 13D and 13G filings for Nasus Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-20 4:55 pm Purchase | 2025-08-14 | 13G | NASUS PHARMA LTD NSRX | Capital Point Ltd. | 575,129 6.350% | 575,129 (New Position) | Filing |